4//SEC Filing
HURLY STEPHEN A 4
Accession 0001485003-18-000014
CIK 0001485003other
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 4:23 PM ET
Size
5.6 KB
Accession
0001485003-18-000014
Insider Transaction Report
Form 4
HURLY STEPHEN A
DirectorPresident and CEO
Transactions
- Award
Common Stock
2018-03-14+105,000→ 105,000 totalExercise: $1.59From: 2018-03-14Exp: 2027-10-03→ Common Stock (105,000 underlying)
Footnotes (1)
- [F1]On October 4, 2017, the reporting person was granted an option to purchase 420,000 shares of common stock. This option vests in installments based on the achievement of certain strategic and clinical milestones. On March 14, 2018, the Compensation Committee of the Board of Directors of the Company determined that one of these performance milestones was met, resulting in vesting of the option with respect to 105,000 shares.
Documents
Issuer
Eleven Biotherapeutics, Inc.
CIK 0001485003
Entity typeother
Related Parties
1- filerCIK 0001130637
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 4:23 PM ET
- Size
- 5.6 KB